Biodesix exec tapped for Colorado BioScience Association board
BOULDER — Robin Harper Cowie, Biodesix Inc. (Nasdaq: BDSX) chief financial officer, has been appointed to the Colorado BioScience Association board of directors.
Her “expertise will play a crucial role in driving the growth and development of Colorado’s thriving life sciences community,” the company said in a news release. “In joining the CBSA board, Harper Cowie will collaborate with fellow industry leaders to bolster the supportive ecosystem for life sciences companies throughout the state.”
Biodesix is a life-sciences company that specializes in developing tools to detect lung disease.
“Biodesix has established a culture of innovation and collaboration, and my appointment to the board…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have completed a…
-
Biodesix Inc. (Nasdaq: BDSX), a life-sciences company that specializes in developing tools to detect lung…
